ArticleJournal of managed care & specialty pharmacy2024

Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metastatic non-small cell lung cancer.

Christine M Bestvina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.